Clinical Trials on Female Ductal Carcinoma In Situ in Canada

Total 2600 results

Sunnybrook Health Sciences Centre

Terminated

Diagnostic Study of Early Breast Cancer Using Ultrasound

Ductal Carcinoma In-situ

Canada
Toronto Sunnybrook Regional Cancer Centre
Canadian Breast Cancer Foundation

Completed

The Prone Breast Radiation Therapy Trial

Invasive Breast Cancer | Ductal Carcinoma In Situ

Canada
McMaster University
St. Joseph's Healthcare Hamilton; Hamilton Health Sciences Corporation

Unknown

Axillary Reverse Mapping (ARM) Technique (ARM)

Invasive Breast Cancer | Ductal Carcinoma in Situ of the Breast

Canada
Virginia Commonwealth University
National Cancer Institute (NCI)

Completed

Hormone Therapy Or Chemotherapy Before Surgery Based on Gene Expression Analysis in Treating Patients With Breast Cancer

Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Ductal Breast Carcinoma in Situ | Lobular Breast Carcinoma in Situ

United States, Canada
Ontario Clinical Oncology Group (OCOG)

Recruiting

Prospective Evaluation of Breast-Conserving Surgery Alone in Low-Risk Ductal Carcinoma in Situ (DCIS) (ELISA)

DCIS

Canada
National Cancer Institute (NCI)
NRG Oncology

Active, not recruiting

Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy

Breast Ductal Carcinoma In Situ

United States, Canada, Puerto Rico, Korea, Republic of
Sunnybrook Health Sciences Centre
University of Toronto; Sunnybrook Research Institute

Completed

Metformin With Neoadjuvant Chemoradiation to Improve Pathologic Responses in Rectal Cancer

Rectal Neoplasm Carcinoma in Situ Adenocarcinoma

Canada
Trans Tasman Radiation Oncology Group
European Organisation for Research and Treatment of Cancer - EORTC; NCIC Clinical... and other collaborators

Active, not recruiting

Radiation Doses and Fractionation Schedules in Non-low Risk Ductal Carcinoma In Situ (DCIS) of the Breast (DCIS)

Carcinoma, Ductal, Breast

United Kingdom, Netherlands, Ireland, Switzerland, Australia, Singapore, New Zealand, Belgium, Canada, Italy, France
NSABP Foundation Inc
National Cancer Institute (NCI); Southwest Oncology Group; North Central Cancer... and other collaborators

Completed

Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy

Breast Cancer

United States, Canada, Puerto Rico
National Cancer Institute (NCI)

Active, not recruiting

Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer

Breast Ductal Carcinoma In Situ | Invasive Breast Carcinoma | Multicentric Breast Carcinoma | Multifocal Breast Carcinoma | Synchronous Bilateral Breast Carcinoma

United States, France, Spain, Canada, Saudi Arabia, Puerto Rico, Korea, Republic of, Ireland, Colombia, Mexico
Sunnybrook Health Sciences Centre
Merck Canada Inc.

Active, not recruiting

In the Era of the HPV Vaccine, What Are The Current HPV Subtypes Contributing to High Grade Cervical Dysplasia, Adenocarcinoma in Situ, and Early Cervical Cancer?

HSIL, High-Grade Squamous Intraepithelial Lesions | Adenocarcinoma in Situ | Early Cervical Cancer

Canada
Fidia Farmaceutici s.p.a.

Recruiting

Study of ONCOFID-P-B (PACLITAXEL-HYALURONIC ACID)

Bladder Carcinoma in Situ (CIS)

United States, Spain, Italy, France, Poland
McMaster University
Canadian Breast Cancer Foundation

Completed

Trial Comparing Radioactive Seed Localization to Standard Procedure for Non-palpable Breast Cancers

Breast Cancer Invasive Nos | Stage 0 Breast Carcinoma

Canada
Sunnybrook Health Sciences Centre

Active, not recruiting

Using Clinicopathomic Markers to Predict Neoadjuvant Chemotherapy Response in Breast Cancer

Breast Cancer | Invasive Lobular Breast Carcinoma | Invasive Ductal Breast Carcinoma

Canada
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

Reflectance Confocal Imaging in Cervical Cancer Patients

Cervical Cancer

United States, Canada
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

Molecular Imaging for Detection of Cervical Intraepithelial Neoplasia

Cervical Cancer

United States, Canada
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Terminated

Spectroscopy Versus Standard Care in Cervical Cancer Patients

Cervical Cancer

United States, Canada
British Columbia Cancer Agency
National Cancer Institute (NCI)

Completed

Digital Colposcopy in Finding Cervical Intraepithelial Neoplasia

Cervical Cancer | Precancerous Condition

Canada
British Columbia Cancer Agency
National Cancer Institute (NCI)

Withdrawn

Digital Colposcopy in Finding Cervical Intraepithelial Neoplasia in Patients With An Abnormal Pap Smear

Cervical Cancer | Precancerous Condition

Canada
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

Measurement of Digital Colposcopy for Fluorescence Spectroscopy of Cervical Intraepithelial Neoplasia

Cervical Cancer

United States, Canada, Nigeria
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

Fluorescence and Reflectance Spectroscopy During Colposcopy in Detecting Cervical Intraepithelial Neoplasia and Dysplasia in Healthy Participants With a History of Normal Pap Smears

Cervical Cancer | Precancerous Condition

United States, Canada
Astellas Pharma Global Development, Inc.
Seagen Inc.

Recruiting

A Study of Intravesical Enfortumab Vedotin For Treatment of Patients With Non-muscle Invasive Bladder Cancer (NMIBC)

Carcinoma in Situ | Urinary Bladder Neoplasms | Non-muscle Invasive Bladder Cancer | Carcinoma Transitional Cell | NMIBC

United States, Canada, France, Spain, United Kingdom
Ottawa Hospital Research Institute

Unknown

A Feasibility Study for Women Receiving Anthracycline Chemotherapy With or Without Radiation for HER2-neu Positive Invasive Ductal Carcinoma (OTT14-01)

Breast Cancer

Canada
University of British Columbia
British Columbia Cancer Agency; Women's Health Research Institute of British...

Completed

The SAFE Study: Satisfaction and Adherence to Follow-Up With Colposcopy Exams

Uterine Cervical Dysplasia | Uterine Cervix Cancer

Canada
British Columbia Cancer Agency
M.D. Anderson Cancer Center; National Cancer Institute (NCI); The University... and other collaborators

Completed

Combined Digital Colposcopy Analysis to Improve Cervical Precancer and Cancer Detection (MDC_Algo)

Cervical Cancer | Precancerous Condition

United States, Canada
Ontario Clinical Oncology Group (OCOG)

Completed

Evaluation of the DCIS Score for Decisions on Radiotherapy in Patients With Low/Intermediate Risk DCIS (DUCHESS)

DCIS

Canada
NCIC Clinical Trials Group

Completed

Vitamin E, Selenium, and Soy Protein in Preventing Cancer in Patients With High-Grade Prostate Neoplasia

Prostate Cancer | Precancerous/Nonmalignant Condition

Canada
University Health Network, Toronto

Active, not recruiting

Study of Changes and Characteristics of Genes in Patients With Pancreatic Cancer for Better Treatment Selection (COMPASS)

Carcinoma, Pancreatic Ductal

Canada
McGill University

Completed

Cervical And Self-Sample In Screening Study (CASSIS)

Cervical Cancer | Intraepithelial Neoplasia

Canada
Agensys, Inc.

Completed

A Study of AGS-1C4D4 in Pancreatic Cancer Subjects Previously Treated in Protocol 2008002

Pancreatic Cancer | Pancreatic Disease | Carcinoma, Pancreatic Ductal

United States, Canada
Lawson Health Research Institute
Academic Medical Organization of Southwestern Ontario

Active, not recruiting

Preventing Toxicity in Renal Cancer Patients Treated With Immunotherapy Using Fecal Microbiota Transplantation (PERFORM)

Renal Cell Carcinoma

Canada
University Health Network, Toronto
Celsius Therapeutics

Active, not recruiting

Renal Cell Carcinoma Microenvironment Discovery Project (REMEDY)

Renal Cell Carcinoma

Canada
AHS Cancer Control Alberta
EMD Serono

Active, not recruiting

Avelumab With Valproic Acid in Virus-associated Cancer (LATENT)

Squamous Cell Carcinoma of the Cervix | Cancer That is Associated With a Chronic Viral Infection | p16 Positive SCCHN | p16 Positive Squamous Cell Carcinoma of the Vagina or Vulva | p16 Positive Squamous Cell Carcinoma of the Penis | p16 Positive Squamous Cell Carcinoma of the Anus or Anal... and other conditions

Canada
Children's Oncology Group
National Cancer Institute (NCI)

Recruiting

Web-Based Physical Activity Intervention in Improving Long Term Health in Children and Adolescents With Cancer

Malignant Solid Neoplasm | Carcinoma In Situ | Hematopoietic and Lymphatic System Neoplasm

United States, Canada
Pfizer

Terminated

A Study to Learn About the Effect of Avelumab First-Line Maintenance in Canadian People With Advanced Bladder Cancer

Urinary Bladder Neoplasms | Bladder Cancer | Urothelial Carcinoma | Bladder Tumors

Canada
Sunnybrook Health Sciences Centre
Juravinski Cancer Center

Active, not recruiting

Assessment of QoL and Outcomes With SBRT for RCC (AQuOS-RCC)

Renal Cell Carcinoma

Canada
Inovio Pharmaceuticals

Completed

VGX-3100 Delivered Intramuscularly (IM) Followed by Electroporation (EP) for the Treatment of HPV-16 and/or HPV-18 Related Anal or Anal/Peri-Anal, High Grade Squamous Intraepithelial Lesion (HSIL) in Individuals Seronegative for Human Immunodeficiency Virus (HIV)-1/2

Anal Neoplasm

United States, Canada
Ontario Clinical Oncology Group (OCOG)
Canadian Institutes of Health Research (CIHR)

Completed

Immediate Treatment vs Colposcopic Follow-up for Biopsy-Proven CIN 1

Cervical Intraepithelial Neoplasia

Canada, Brazil
University Health Network, Toronto

Recruiting

A Study of Various Treatments in Serous or p53 Abnormal Endometrial Cancer (CAN-STAMP)

Endometrial Carcinoma | P53 Mutation | Serous Carcinoma

Canada
British Columbia Cancer Agency
Canadian Cancer Trials Group; Australia New Zealand Gynaecological Oncology... and other collaborators

Not yet recruiting

STRatIfication of Vulvar Squamous Cell Carcinoma by HPV and p53 Status to Guide Excision (STRIVE)

Vulvar Cancer

Canada
University Health Network, Toronto
University of Amsterdam

Recruiting

Breathomics as Predictive Biomarker for Checkpoint Inhibitor Response

Melanoma | Kidney Cancer | Head and Neck Cancer | NSCLC | Urothelial Carcinoma

Canada
University of Alberta

Suspended

Study of Minimally-invasive Ablative Renal Therapies (SMART) Registry (SMART)

Renal Cancer

Canada
National Cancer Institute (NCI)

Withdrawn

Testing Anti-Cancer Drugs Erdafitinib With or Without Atezolizumab in Patients With Localized Bladder Cancer Not Able to Receive Cisplatin Chemotherapy, NERA Trial

Urothelial Carcinoma | Renal Pelvis and Ureter Urothelial Carcinoma | Bladder Carcinoma | Stage III Bladder Cancer AJCC v8 | Stage IVA Bladder Cancer AJCC v8 | Bladder Urothelial Carcinoma | Muscle Invasive Bladder Carcinoma | Stage II Bladder Cancer AJCC v8

Canada
Sir Mortimer B. Davis - Jewish General Hospital

Terminated

Two TraCer PositROn EmiSSion Tomography ComBination for Efficacy EstimatiOn of Prostate Specific Membrane Antigen Radioligand Therapy in Patients With Metastatic Prostate Cancer (CROSSBOW)

Prostatic Neoplasms | Prostate Cancer | Metastatic Prostate Cancer | Prostate Adenocarcinoma | Metastatic Prostatic Adenocarcinoma | Metastatic Prostate Carcinoma in the Soft Tissue

Canada
University Health Network, Toronto

Active, not recruiting

Pembrolizumab in Small Cell Carcinoma of Ovary - Hypercalcemic Type Patient (Pemb-HT)

Ovarian Cancer | Small Cell Carcinoma, Hypercalcaemic Type

Canada
University Health Network, Toronto

Recruiting

Virtual Rehabilitation for Cancer Survivors

Lymphoma | Lymphoproliferative Disorders | Breast Cancer Stage I | Breast Cancer Stage II | Colorectal Cancer Stage II | Colorectal Cancer Stage III | Breast Cancer Stage III | Colorectal Cancer Stage I | Head and Neck Cancer Stage III | Breast Cancer, Stage 0 | Head and Neck Cancer Stage I | Head and Neck Cancer...

Canada
Ontario Clinical Oncology Group (OCOG)
Bristol-Myers Squibb

Active, not recruiting

SBRT With Combination Ipilimumab/Nivolumab for Metastatic Kidney Cancer (CYTOSHRINK)

Metastatic Renal Cell Carcinoma

Canada, Australia
Ontario Clinical Oncology Group (OCOG)
Cancer Care Ontario

Active, not recruiting

Impact of Positron Emission Tomography (PET) Imaging in Muscle-invasive Urothelial Carcinoma of the Bladder Staging (PET MUSE)

Muscle-invasive Bladder Cancer

Canada
National Cancer Institute (NCI)

Active, not recruiting

Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer

Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Advanced Malignant Solid Neoplasm | Stage III Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Clinical Stage III Gastric Cancer AJCC v8 | Clinical Stage IV Gastric Cancer AJCC v8 | Triple-Negative Breast Carcinoma and other conditions

United States, Canada
University Health Network, Toronto

Terminated

Capturing BRCA1/2 Mutational Status in Women With High Grade Serous Ovarian Cancer and Impact on Clinical Outcome.

Ovarian Cancer

Canada

Clinical Trials on Female Ductal Carcinoma In Situ in Canada

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Thailand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations